Navigating the FDA’s LDT Final Rule: The Role of Medical Lab Software in Compliance

 

On May 6, 2024, the U.S. Food and Drug Administration (FDA) issued a final rule designed to ensure the safety and effectiveness of laboratory-developed tests (LDTs). Starting in 2025, the FDA's final rule will gradually increase the regulatory burden on diagnostics by enforcing new guidelines for LDTs. Is your lab ready to face the regulatory whirlwind?

Our latest blog sheds light on the key components of the FDA’s LDT Final Rule and how a Laboratory Information Management System (LIMS) can help you streamline lab processes and meet the FDA’s rigorous guidelines.

In this blog, we cover:

  • Key aspects of the FDA’s LDT final rule
  • Impact of the LDT final rule on laboratories
  • How medical laboratory management software can help labs comply with the requirements of the FDA’s LDT final rule

Don’t miss this chance to get ahead of the regulatory shift. Read the blog now!

Comments

Post a Comment

Popular posts from this blog

Leverage LIS Software for Veterinary Laboratories to Build Robust Testing Labs

Image
  Veterinary diagnostics is expanding at an unprecedented pace. As pet owners demand high-quality diagnostics and livestock operations rely on rapid, high-throughput testing to manage herd health and food safety, veterinary laboratories need to deliver faster results without compromising accuracy, traceability, or trust. In this blog, you’ll learn: The challenges veterinary labs face—from sample complexity and heterogeneous data integration to compliance and staffing requirements Best practices for building a robust veterinary laboratory Strategies and tools that help labs follow best practices with ease and deliver high-quality diagnostics Read the Blog
Read more

Debra Leiolani Garcia, a Biobanking Operations Expert, Joins CloudLIMS’ Scientific Advisory Board

Image
Wilmington, Delaware — September 17, 2025  — CloudLIMS, a  SOC 2 compliant  and  ISO 9001:2015  certified LIMS software provider, is pleased to announce that Ms. Debra Leiolani Garcia, an accomplished leader with over 25 years of experience in biobanking operations and governance, has joined CloudLIMS’ Scientific Advisory Board (SAB). Ms. Garcia brings unparalleled expertise in the operational, regulatory, and strategic aspects of biobanking. Collaboration is central to CloudLIMS’ vision, and we believe that Ms. Garcia’s contributions will help further strengthen our ability to serve the global biobanking community. She will contribute her decades of expertise to CloudLIMS, supporting the ongoing development of our  robust biobanking software  designed to meet the current and future challenges of biobanks — ranging from secure data management and regulatory compliance to automation, standardization, and sustainability. Ms. Garcia earned her B.S. in Mic...
Read more

From Audit Stress to FDA Readiness: How LIMS for Food and Beverage Labs Supports FSMA Compliance

Image
  Food safety has entered a prevention-first era. With the Food Safety Modernization Act (FSMA), laboratories and food manufacturers are now expected to demonstrate continuous preventive control, traceability, and inspection readiness—long before an FDA investigator arrives. In this blog, you’ll learn: What FSMA is, how its rules apply to food testing laboratories, and recent FSMA updates The LAAF program requirements and when LAAF-accredited testing is mandatory 8 Tips to prepare for an FDA inspection How a modern LIMS supports FSMA compliance and FDA inspection readiness Read the Blog
Read more